- Home
- GNFT vs EMF Comparison
GNFT vs EMF Comparison
Compare GNFT & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- EMF
- Stock Information
- Founded
- GNFT 1999
- EMF 1987
- Country
- GNFT France
- EMF United States
- Employees
- GNFT N/A
- EMF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- EMF Finance/Investors Services
- Sector
- GNFT Health Care
- EMF Finance
- Exchange
- GNFT Nasdaq
- EMF Nasdaq
- Market Cap
- GNFT 172.2M
- EMF 192.8M
- IPO Year
- GNFT 2019
- EMF N/A
- Fundamental
- Price
- GNFT $3.60
- EMF $12.21
- Analyst Decision
- GNFT Strong Buy
- EMF
- Analyst Count
- GNFT 1
- EMF 0
- Target Price
- GNFT $13.00
- EMF N/A
- AVG Volume (30 Days)
- GNFT 3.9K
- EMF 29.3K
- Earning Date
- GNFT 09-19-2024
- EMF 01-01-0001
- Dividend Yield
- GNFT N/A
- EMF 6.16%
- EPS Growth
- GNFT N/A
- EMF N/A
- EPS
- GNFT 0.47
- EMF N/A
- Revenue
- GNFT $86,225,222.00
- EMF N/A
- Revenue This Year
- GNFT $145.20
- EMF N/A
- Revenue Next Year
- GNFT N/A
- EMF N/A
- P/E Ratio
- GNFT $7.58
- EMF N/A
- Revenue Growth
- GNFT 175.45
- EMF N/A
- 52 Week Low
- GNFT $3.35
- EMF $10.58
- 52 Week High
- GNFT $6.42
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- GNFT 42.09
- EMF 50.18
- Support Level
- GNFT $3.35
- EMF $12.02
- Resistance Level
- GNFT $3.66
- EMF $12.24
- Average True Range (ATR)
- GNFT 0.10
- EMF 0.11
- MACD
- GNFT 0.03
- EMF 0.06
- Stochastic Oscillator
- GNFT 45.45
- EMF 77.59
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.